306 related articles for article (PubMed ID: 32279919)
1. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
Kanwar MK; Rajagopal K; Itoh A; Silvestry SC; Uriel N; Cleveland JC; Salerno CT; Horstmanshof D; Goldstein DJ; Naka Y; Bailey S; Gregoric ID; Chuang J; Sood P; Mehra MR
J Heart Lung Transplant; 2020 Jun; 39(6):529-537. PubMed ID: 32279919
[TBL] [Abstract][Full Text] [Related]
2. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
[TBL] [Abstract][Full Text] [Related]
3. Validation of mitral regurgitation reversibility in patients with HeartMate 3 LVAD implantation.
Schreiber C; Dieterlen MT; Garbade J; Borger MA; Sieg F; Spampinato R; Dobrovie M; Meyer AL
Artif Organs; 2022 Jan; 46(1):106-116. PubMed ID: 34398476
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
Uriel N; Milano C; Agarwal R; Lee S; Cleveland J; Goldstein D; Wang A; Crandall D; Mehra MR
Eur J Heart Fail; 2023 Feb; 25(2):286-294. PubMed ID: 36404406
[TBL] [Abstract][Full Text] [Related]
5. Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation.
Kawabori M; Kurihara C; Conyer RT; Critsinelis AC; Sugiura T; Rosengart T; Morgan JA
J Artif Organs; 2019 Jun; 22(2):91-97. PubMed ID: 30361785
[TBL] [Abstract][Full Text] [Related]
6. Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation.
Pawale A; Itagaki S; Parikh A; Pinney SP; Adams DH; Anyanwu AC
J Thorac Cardiovasc Surg; 2019 May; 157(5):1841-1848.e1. PubMed ID: 31288361
[TBL] [Abstract][Full Text] [Related]
7. Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion.
Sandoval E; Singh SK; Carillo JA; Baldwin ACW; Ono M; Anand J; Frazier OH; Mallidi HR
Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):620-623. PubMed ID: 28962504
[TBL] [Abstract][Full Text] [Related]
8. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.
Kitada S; Kato TS; Thomas SS; Conwell SD; Russo C; Di Tullio MR; Farr M; Schulze PC; Uriel N; Jorde UP; Takayama H; Naka Y; Homma S; Mancini DM
J Heart Lung Transplant; 2013 Sep; 32(9):897-904. PubMed ID: 23850122
[TBL] [Abstract][Full Text] [Related]
10. Impact of Residual Mitral Regurgitation on Right Ventricular Systolic Function After Left Ventricular Assist Device Implantation.
Ertugay S; Kemal HS; Kahraman U; Engin C; Nalbantgil S; Yagdi T; Ozbaran M
Artif Organs; 2017 Jul; 41(7):622-627. PubMed ID: 27873344
[TBL] [Abstract][Full Text] [Related]
11. Impact of Concomitant Mitral Valve Surgery With LVAD Placement: Systematic Review and Meta-Analysis.
Choi JH; Luc JGY; Moncho Escrivá E; Phan K; Rizvi SSA; Patel S; Entwistle JW; Morris RJ; Massey HT; Tchantchaleishvili V
Artif Organs; 2018 Dec; 42(12):1139-1147. PubMed ID: 30101551
[TBL] [Abstract][Full Text] [Related]
12. Residual mitral regurgitation in patients with left ventricular assist device support - An INTERMACS analysis.
Jain R; Truby LK; Topkara VK
J Heart Lung Transplant; 2022 Nov; 41(11):1638-1645. PubMed ID: 35379546
[TBL] [Abstract][Full Text] [Related]
13. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
[TBL] [Abstract][Full Text] [Related]
15. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
John R; Kanwar MK; Cleveland JC; Uriel N; Naka Y; Salerno C; Horstmanshof D; Hall SA; Cowger JA; Heatley G; Somo SI; Mehra MR
J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1684-1694.e18. PubMed ID: 35643769
[TBL] [Abstract][Full Text] [Related]
16. Reversibility of severe mitral valve regurgitation after left ventricular assist device implantation: single-centre observations from a real-life population of patients.
Dobrovie M; Spampinato RA; Efimova E; da Rocha E Silva JG; Fischer J; Kuehl M; Voigt JU; Belmans A; Ciarka A; Bonamigo Thome F; Schloma V; Dmitrieva Y; Lehmann S; Hahn J; Strotdrees E; Mohr FW; Garbade J; Meyer AL
Eur J Cardiothorac Surg; 2018 Jun; 53(6):1144-1150. PubMed ID: 29351635
[TBL] [Abstract][Full Text] [Related]
17. Consequences of functional mitral regurgitation and atrial fibrillation in patients with left ventricular assist devices.
Hayashi H; Naka Y; Sanchez J; Takayama H; Kurlansky P; Ning Y; Topkara VK; Yuzefpolskaya M; Colombo PC; Sayer GT; Uriel N; Takeda K
J Heart Lung Transplant; 2020 Dec; 39(12):1398-1407. PubMed ID: 32994093
[TBL] [Abstract][Full Text] [Related]
18. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
[TBL] [Abstract][Full Text] [Related]
19. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival.
Tanaka A; Onsager D; Song T; Cozadd D; Kim G; Sarswat N; Adatya S; Sayer G; Uriel N; Jeevanandam V; Ota T
Ann Thorac Surg; 2017 Mar; 103(3):725-733. PubMed ID: 27659599
[TBL] [Abstract][Full Text] [Related]
20. Predictors and clinical implications of residual mitral regurgitation following left ventricular assist device therapy.
Sharma H; Liu B; Yuan M; Shakeel I; Morley-Smith A; Hatch A; Bradley J; Chue C; Myerson SG; Steeds RP; Lim S
Open Heart; 2023 Jun; 10(1):. PubMed ID: 37316326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
